EPH198 Assessing the Validity of Netherlands Linked Routine Healthcare Resource Utilisation Data in the Investigation of Single-Inhaler Triple Therapy Effectiveness (INTREPID Trial)

B Numbere,E Smits,E Holthuis,Y Lu,M Fry,C Compton,As Ismaila,Kj Rothnie

doi:10.1016/j.jval.2022.09.1119

EPH198 Assessing the Validity of Netherlands Linked Routine Healthcare Resource Utilisation Data in the Investigation of Single-Inhaler Triple Therapy Effectiveness (INTREPID Trial)

B Numbere, E Smits + Show 6 more

Open Access

https://doi.org/10.1016/j.jval.2022.09.1119

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Dec 1, 2022
License type: publisher-specific-oa

Affiliation: Health Economics and Outcomes Research (United Kingdom), Pharmo Institute, Age UK, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States)

#Healthcare Resource Utilisation Data #Single-Inhaler Triple Therapy + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

EPH198 Assessing the Validity of Netherlands Linked Routine Healthcare Resource Utilisation Data in the Investigation of Single-Inhaler Triple Therapy Effectiveness (INTREPID Trial)

Full Text